Electrophysiology Device Market Set to Surpass USD 31.52 Billion by 2031, Driven by New Product Launches and Clinical Progress

Posted on | by Markets Glob
Electrophysiology (EP) Device Market
The Electrophysiology (EP) Device Market is growing fast. In 2024, it reached USD 12,215.08 million, and by 2031, it is expected to hit USD 31,516.26 million.

The Electrophysiology (EP) Device Market is growing fast. In 2024, it reached USD 12,215.08 million, and by 2031, it is expected to hit USD 31,516.26 million. This growth reflects a strong demand for advanced heart care devices, especially in treating atrial fibrillation (AF) and ventricular tachycardia (VT).

What Are Electrophysiology Devices?

Electrophysiology devices are used by doctors to study and treat problems in the heart’s electrical system. These devices help find abnormal heart rhythms and guide procedures like cardiac ablation. They include catheters, mapping systems, and other tools used during diagnosis and treatment.

Rising Procedures and Demand for EP Devices

The number of catheter ablation procedures is growing each year. This leads to a higher demand for related products. EP devices are getting better too. Today’s devices are more flexible, easier to guide through complex heart structures, and provide better visuals through imaging. According to an article from Elsevier Inc. (March 2023), the annual rate of EP procedures in the U.S. rose from 817.9 in 2013 to 1,089.68 per 100,000 people in 2019.

Another key driver is the rising number of arrhythmia cases, especially AFib. As per a report from Johnson & Johnson Services, Inc. (2021–22), AFib affects over 7 million people in the U.S., 20 million in Asia Pacific, 14 million in Europe, and nearly 2 million in Latin America. In Europe, major countries like France, Germany, Italy, and the UK each have more than 1 million cases. The aging population in these regions is pushing AFib numbers even higher. By 2050, Europe is expected to see the biggest rise in AFib cases, leading to more strokes, hospital stays, and clinic visits — all of which increase the need for electrophysiology devices.

Key Developments Pushing the Market Forward

Several leading companies have made big moves recently that are helping the electrophysiology device market grow:

  1. Abbott made headlines in October 2024 by completing enrollment for its global clinical study of the Volt™ Pulsed Field Ablation (PFA) System ahead of schedule. The company also launched the FOCALFLEX trial for its TactiFlex™ Duo Ablation Catheter. To top it off, Abbott received FDA approval for its Advisor™ HD Grid X Mapping Catheter, which improves heart mapping during procedures. source
  2. Biosense Webster, part of Johnson & Johnson MedTech, got the green light in Japan for its VARIPULSE™ PFA Platform in January 2024. It’s the first full PFA system approved in Japan, offering better real-time mapping with the CARTO™ 3 System. This is a major step for patients with hard-to-treat paroxysmal atrial fibrillation. source
  3. Boston Scientific also made strides in October 2024, launching its FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software. These tools support the FARAPULSE™ PFA System and give doctors more control and visibility during heart procedures. The magnetic navigation system improves accuracy during treatments. source
  4. Medtronic reached a key milestone in June 2024 with its Affera Mapping and Ablation System. Clinical trial results showed the system is safe and effective, especially the Sphere-9 Catheter, which had better results than standard treatments. The company has applied for U.S. approval of this system. source

Market Overview and Segments

The electrophysiology device market is divided into several product types:

  • EP Ablation Catheters

  • EP Diagnostic Catheters

  • EP Mapping/Recording Systems

  • LAA (Left Atrial Appendage) Devices

  • Others

It serves two main application areas:

  • Atrial Fibrillation (AF)

  • Ventricular Tachycardia (VT)

Sales channels are:

  • Direct Channel

  • Distribution Channel

The market spans several regions:

  • North America (U.S., Canada, Mexico)

  • Europe (Germany, UK, France, etc.)

  • Asia-Pacific (China, Japan, India, etc.)

  • South America (Brazil, Argentina, etc.)

  • Middle East & Africa (UAE, South Africa, etc.)

Major Market Players

Key companies in this market include:

These companies are working hard to bring better solutions to doctors and patients worldwide.

As technology improves and more people need heart care, the electrophysiology device market is expected to grow rapidly. With new products and approvals coming regularly, this market is one to watch closely